Guardant Health and Quest Diagnostics will collaborate to offer Guardant’s Shield blood-based colorectal cancer test through ...

A colonoscopy is still the gold standard. It can find and remove precancerous growths during the same procedure, which no ...

Guardant Health, Inc. announced the availability of Shield, the company's first blood-based test for the detection of early-stage colorectal cancer. automation The U.S. Food and Drug Administration on ...

The tests look for bits of altered DNA that cancer cells shed into the bloodstream. The screening technology holds hope of finding cancers early, when they might be cured.

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of removing tissue from the body. Traditional biopsies involve surgery, needles, ...

A circulating tumor DNA (ctDNA) blood test demonstrated high sensitivity and specificity for colorectal cancer (CRC) detection in a large average-risk population, study finds. A blood-based ...

A new blood-based test for colorectal cancer currently up for FDA review could mean cheaper and less invasive screenings for the disease. Doctors and advocates have been waiting for years for a new ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A blood test for colon cancer performed well ...

A woman was diagnosed with stage-3 colon cancer at age 24 and said she almost missed a major warning sign of the disease.